Related StoriesYK-4-279 compound functions against some types of leukemia: StudyTargeting exhausted immune cells may change prognosis for leukemia relapse sufferers after transplantNew study reveals that social factors may impact critical areas of wellness in AML patientsOther important results from the CAS record include: Over the last 20 years, cancers therapy journal publications grew 179 %, while patent publications grew 318 %. From 1990 to 2009, journal content publications about CML treatment expanded 196 %. At the same time, patent publications exploded with 700 % growth. The Globe Intellectual Patent Company may be the leading patent authority for Gleevec use in CML.S. Experts authored 3 x as many journal publications for Gleevec as any additional country.The Berkeley MBA faculty and students will work with the winners to evaluate a specific metrics challenge, recommend a solution, and provide an implementation plan through the semester-long training course from August to December 2015. Establishing meaningful metrics is critical for nonprofits to improve their effect on the lives of these they serve and demonstrate leads to funders, said Colin Boyle, deputy director of University of California, SAN FRANCISCO BAY AREA Global Health Solutions and the Haas faculty member who will be teaching this program. The partnership was formed based on the outcomes of a study of cancer nonprofit agencies carried out by Amgen in 2013.